Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon

Area of Science:

• Immunology
• Nephrology
• Genetics

Background:

• Partial lipodystrophy (PLD) is a rare disorder characterized by fat loss, often from the upper body.
• PLD is frequently associated with mesangiocapillary glomerulonephritis Type II (MCGN II).
• Complement system dysfunction has been observed in patients with PLD and/or MCGN II.

Purpose of the Study:

• To explore the association between PLD, MCGN II, and C3 nephritic factor (C3NeF).
• To investigate the role of complement deficiency in triggering autoimmune diseases in this context.

Main Methods:

• Review of case reports and studies linking PLD, MCGN II, and C3NeF.
• Analysis of the immunological targets of C3NeF, specifically the alternative pathway C3 convertase (C3bBb).

Main Results:

• An IgG autoantibody, C3NeF, targeting the alternative pathway C3 convertase, is frequently detected.
• Sporadic reports link PLD, MCGN II, and C3NeF with autoimmune diseases, suggesting a potential causal relationship.
• Complement deficiency may lead to immune system perturbations, potentially triggering autoimmune conditions.

Conclusions:

• The association between PLD, MCGN II, and C3NeF warrants further investigation.
• Complement system dysfunction may play a significant role in the pathogenesis of associated autoimmune diseases.
• Understanding these links could improve diagnosis and management of these rare conditions.